Vincent T.H.B.M. Smit

20.6k total citations · 6 hit papers
200 papers, 12.0k citations indexed

About

Vincent T.H.B.M. Smit is a scholar working on Oncology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Vincent T.H.B.M. Smit has authored 200 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 57 papers in Obstetrics and Gynecology and 52 papers in Cancer Research. Recurrent topics in Vincent T.H.B.M. Smit's work include Endometrial and Cervical Cancer Treatments (55 papers), Ovarian cancer diagnosis and treatment (42 papers) and Cancer Genomics and Diagnostics (25 papers). Vincent T.H.B.M. Smit is often cited by papers focused on Endometrial and Cervical Cancer Treatments (55 papers), Ovarian cancer diagnosis and treatment (42 papers) and Cancer Genomics and Diagnostics (25 papers). Vincent T.H.B.M. Smit collaborates with scholars based in Netherlands, United Kingdom and United States. Vincent T.H.B.M. Smit's co-authors include Carien L. Creutzberg, Remi A. Nout, Tjalling Bosse, Hein Putter, Cornelis J.�H. van de Velde, Cees J. Cornelisse, Ellen Stelloo, Jan J. Jobsen, Peter J.K. Kuppen and Gerrit‐Jan Liefers and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Vincent T.H.B.M. Smit

194 papers receiving 11.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

2010 785 citations Remi A. Nout, Vincent T.H.B.M. Smit et al. profile →
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

2016 569 citations Ellen Stelloo, Remi A. Nout et al. Clinical Cancer Research profile →
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

1988 531 citations Vincent T.H.B.M. Smit et al. profile →
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

2015 341 citations Ellen Stelloo, Tjalling Bosse et al. profile →
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials

2015 267 citations Tjalling Bosse, Elke E.M. Peters et al. European Journal of Cancer profile →
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

2019 255 citations Alicia León‐Castillo, Remi A. Nout et al. The Journal of Pathology profile →

Peers

Countries citing papers authored by Vincent T.H.B.M. Smit

Since Specialization

Citations

This map shows the geographic impact of Vincent T.H.B.M. Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent T.H.B.M. Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent T.H.B.M. Smit more than expected).

Fields of papers citing papers by Vincent T.H.B.M. Smit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent T.H.B.M. Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent T.H.B.M. Smit. The network helps show where Vincent T.H.B.M. Smit may publish in the future.

Co-authorship network of co-authors of Vincent T.H.B.M. Smit

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent T.H.B.M. Smit. A scholar is included among the top collaborators of Vincent T.H.B.M. Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent T.H.B.M. Smit. Vincent T.H.B.M. Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer 2025 ·Gynecologic Oncology ·Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, Natalja T. ter Haar, Vincent T.H.B.M. Smit, Cor D. de Kroon, (unknown), Estrid Høgdall, Claus Høgdall, (unknown), Carien L. Creutzberg, Tjalling Bosse, Gitte Ørtoft	1
2	TWO-YEAR'S WORSENING OF SEMI-QUANTITATIVE MRI FEATURES AS SURROGATE OUTCOMES FOR LONG-TERM INCIDENT RADIOGRAPHIC KNEE OSTEOARTHRITIS AFTER ACL-RUPTURE 2024 ·J. Runhaar, Belle L. van Meer, Vincent T.H.B.M. Smit, (unknown), Edwin H. G. Oei, Max Reijman, Duncan E. Meuffels	0
3	2022-RA-450-ESGO Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer 2022 ·International Journal of Gynecological Cancer ·Nanda Horeweg, Remi A. Nout, Ellen Stelloo, Ludy Lutgens, Jan J. Jobsen, Ina M. Jürgenliemk‐Schulz, (unknown), (unknown), Annerie Slot, Vincent T.H.B.M. Smit, Tjalling Bosse, Carien L. Creutzberg	1
4	2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study 2022 ·International Journal of Gynecological Cancer ·Lisa Vermij, Hein Putter, Jan J. Jobsen, Melanie Powell, Stephanie M. de Boer, Alexandra Léary, Paul Bessette, Linda Mileshkin, Ludy Lutgens, Ina M. Jürgenliemk‐Schulz, Annerie Slot, Elzbieta van der Steen-Banasik, Remi A. Nout, Vincent T.H.B.M. Smit, Ewout W. Steyerberg, Carien L. Creutzberg, Tjalling Bosse, Nanda Horeweg	1
5	2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers 2022 ·International Journal of Gynecological Cancer ·Lisa Vermij, Jan J. Jobsen, Mariël Brinkhuis, (unknown), Alicia León‐Castillo, Naveena Singh, Linda Mileshkin, Melanie Powell, Prafull Ghatage, (unknown), Alexandra Léary, Catherine Genestie, Hans W. Nijman, Ina M. Jürgenliemk‐Schulz, Remi A. Nout, Vincent T.H.B.M. Smit, Stephanie M. de Boer, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse	1
6	2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials 2022 ·International Journal of Gynecological Cancer ·(unknown), Stephanie M. de Boer, Melanie Powell, Alexandra Léary, Anthony Fyles, Linda Mileshkin, Naveena Singh, Remi A. Nout, Ina M. Jürgenliemk‐Schulz, Jan J. Jobsen, Ludy Lutgens, (unknown), (unknown), Annerie Slot, Hans W. Nijman, Vincent T.H.B.M. Smit, Tjalling Bosse, Carien L. Creutzberg, Nanda Horeweg	1
7	Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer 2021 ·International Journal of Gynecological Pathology ·Elke E.M. Peters, Alicia León‐Castillo, Vincent T.H.B.M. Smit, (unknown), Estrid Høgdall, Claus Høgdall, Carien L. Creutzberg, Ina M. Jürgenliemk‐Schulz, Jan J. Jobsen, Jan Willem Mens, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Gitte Ørtoft, Tjalling Bosse, Remi A. Nout	47
8	Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer 2020 ·Cancer Immunology Research ·Nanda Horeweg, Marco de Bruyn, Remi A. Nout, Ellen Stelloo, (unknown), Alicia León‐Castillo, Annechien Plat, Kirsten D. Mertz, (unknown), Ina M. Jürgenliemk‐Schulz, Ludy Lutgens, Jan J. Jobsen, Elzbieta M. van der Steen‐Banasik, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Tjalling Bosse, Hans W. Nijman, Viktor H. Koelzer, David N. Church	42
9	Germline BRCA -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity 2019 ·Clinical Cancer Research ·Marthe M. de Jonge, Lauren L. Ritterhouse, Cor D. de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal, (unknown), Harry Hollema, Matti A. Rookus, Christi J. van Asperen, Flora E. van Leeuwen, Vincent T.H.B.M. Smit, Brooke E. Howitt, Tjalling Bosse	34
10	Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Méder, P.B. Ottevanger, JA Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, (unknown), Ina J. Jürgenliemk-Schulz, H. Kitchener, Hans W. Nijman, Roy F.P.M. Kruitwagen, Vincent T.H.B.M. Smit, Remi A. Nout, Hein Putter, Carien L. Creutzberg	0
11	Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas breakdown → 2019 ·The Journal of Pathology ·Alicia León‐Castillo, (unknown), Remi A. Nout, Vincent T.H.B.M. Smit, Jessica N. McAlpine, Melissa K. McConechy, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Robert A. Soslow, Raji Ganesan, Xavier Matías‐Guiu, Esther Oliva, Beth Harrison, David N. Church, C. Blake Gilks, Tjalling Bosse	255
12	Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues 2018 ·Clinical Cancer Research ·Inge C. van Gool, Emily Rayner, Elisabeth M. Osse, Remi A. Nout, Carien L. Creutzberg, Ian Tomlinson, David N. Church, Vincent T.H.B.M. Smit, Niels de Wind, Tjalling Bosse, Mark Drost	58
13	Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance 2017 ·Clinical Cancer Research ·Linda S. Nooij, Natalja T. ter Haar, Dina Ruano, Natalia Rakislova, Tom van Wezel, Vincent T.H.B.M. Smit, Baptist Trimbos, Jaume Ordï, Mariëtte I.E. van Poelgeest, Tjalling Bosse	117
14	Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature 2017 ·Cancer Immunology Research ·Sara M. Melief, Valeria Visconti, Marten Visser, Merel van Diepen, Ellen Kapiteijn, Joost H. van den Berg, John B.A.G. Haanen, Vincent T.H.B.M. Smit, Jan Oosting, Sjoerd H. van der Burg, Els M.E. Verdegaal	24
15	A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer 2016 ·Clinical Cancer Research ·Charlotte E.S. Hoogstins, Quirijn R.J.G. Tummers, Katja N. Gaarenstroom, Cor D. de Kroon, J. Baptist Trimbos, Tjalling Bosse, Vincent T.H.B.M. Smit, Jaap Vuyk, Cornelis J.�H. van de Velde, Adam F. Cohen, Philip S. Low, Jacobus Burggraaf, Alexander L. Vahrmeijer	211
16	Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts breakdown → 2016 ·Clinical Cancer Research ·Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, Ina J. Jürgenliemk-Schulz, Jan J. Jobsen, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Hans W. Nijman, Hein Putter, Tjalling Bosse, Carien L. Creutzberg, Vincent T.H.B.M. Smit	569
17	POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer 2015 ·Clinical Cancer Research ·Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills, Ellen Stelloo, Emanuele Marchi, Marco de Bruyn, Claire Palles, Remi A. Nout, Cor D. de Kroon, Elisabeth M. Osse, Paul Klenerman, Carien L. Creutzberg, Ian Tomlinson, Vincent T.H.B.M. Smit, Hans W. Nijman, Tjalling Bosse, David N. Church	231
18	Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy 2014 ·Molecular Cancer Therapeutics ·Wendy Onstenk, Jaco Kraan, Bianca Mostert, (unknown), Ayoub Charehbili, Vincent T.H.B.M. Smit, Judith R. Kroep, J.W.R. Nortier, Saskia van de Ven, Joan B. Heijns, Lonneke W. Kessels, Hanneke W.M. van Laarhoven, Monique M.E.M. Bos, Cornelis J.�H. van de Velde, Jan W. Gratama, Anieta M. Sieuwerts, John W.M. Martens, John A. Foekens, Stefan Sleijfer	47
19	Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death 2014 ·Clinical Cancer Research ·Tetje C. van der Sluis, Suzanne van Duikeren, (unknown), Ekaterina S. Jordanova, Elham Beyranvand Nejad, (unknown), Louis Boon, Vincent T.H.B.M. Smit, Marij J.P. Welters, Ferry Ossendorp, Bob van de Water, Ramon Arens, Sjoerd H. van der Burg, Cornelis J.M. Melief	60
20	Tumor stroma ratio as a predictor for response to neoadjuvant chemotherapy (TAC) in breast cancer (BC) : A Dutch Breast Cancer Trialists' Group (BOOG) side-study 2013 ·European Journal of Cancer ·(unknown), Ayoub Charehbili, Vincent T.H.B.M. Smit, Elma Meershoek‐Klein Kranenbarg, R.A.E.M. Tollenaar, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers, J.W.R. Nortier, Wilma E. Mesker, Judith R. Kroep	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact